Answers are grounded in this paper and cite their sources.
Current hepatitis C virus (HCV) treatment guidelines recommend treating HCV/human immunodeficiency virus (HIV)-coinfected individuals similar to HCV-monoinfected individuals. Recently inferior response rates to direct acting antiviral (DAA) therapy in HCV/HIV coinfection have been reported. Our German hepatitis C cohort (GECCO) cohort data show that coinfected patients with liver cirrhosis are less likely to achieve viral eradication.
No takes yet. Share an insight, caveat, or question.
Boesecke et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: